Management and Directors

Glynn Wilson, Ph.D.
Executive Chairman

Dr. Wilson brings an extensive background of success in corporate management and product development with tenures in both major multinational pharmaceutical companies and start-up pharmaceutical/biotech organizations.  Dr. Wilson's former positions include Head of Drug Delivery at SmithKline Beecham Pharmaceuticals, Research Area Head in Advanced Drug Delivery at Ciba-Geigy Pharmaceuticals, and President and co-founder of Auriga Pharmaceuticals.  As Executive Vice President of R&D at Tacora Corporation he was responsible for merging the Company with Access Pharmaceuticals.   He is a recognized leader in the development of drug delivery systems and has been involved in taking lead products & technologies from concept to commercialization.  Glynn has a Ph.D. in Biochemistry and conducted medical research at The Rockefeller University, New York. He has been on the Board of TapImmune for 4 years.

Denis D Corin
President and CFO
Denis Corin served as TapImmune’s President and CEO from Nov 2006 to July 1st 2009. He is a management consultant with experience in large pharmaceutical (Novartis), diagnostic instrumentation companies (Beckman Coulter) as well as the small cap biotech arena (MIV Therapeutics). He holds a double major Bachelors degree in Economics and Marketing from the University of Natal, South Africa.